BG Medicine Offering $2.1M in Stocks, Warrants | GenomeWeb

NEW YORK (GenomeWeb News) – BG Medicine announced today a public offering of units comprising its common stock and warrants that is expected to bring in net proceeds of $2.1 million.

The Waltham, Massachusetts-based firm is offering 2,315,654 Series A units each consisting of one share of common stock and one half of a warrant to purchase one share of common stock at $1 per Series A unit.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.